Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status (HORM)

H

Hopital Foch

Status

Withdrawn

Conditions

Prostate Cancer

Treatments

Procedure: Trans-rectal biopsy
Biological: intra-prostatic concentration of sexual steroids

Study type

Interventional

Funder types

Other

Identifiers

NCT03014973
2016/03
2016-A00020-51 (Other Identifier)

Details and patient eligibility

About

The main objective of the study is to determine the intra-prostatic concentration of sexual steroids when castration resistance appears in castration-resistant prostate cancer patients compared to patients naif of hormonal treatment

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • group 1: patients with a locally advanced prostate cancer naif of any hormonal treatment
  • group 2: Patients with a castration-resistant prostate cancer resisting defined by a biological progression
  • group 2a: without radiotherapy
  • group 2b: with radiotherapy
  • Affiliated to a social security scheme
  • Having given a written consent.

Exclusion criteria

  • Patient unable to supply a written consent (patient not understanding French, under guardianship patient).
  • neuro-endocrine form or sarcomatoid form prostate cancer

Trial design

0 participants in 2 patient groups

prostate cancer patients resistant to castration
Experimental group
Treatment:
Biological: intra-prostatic concentration of sexual steroids
Procedure: Trans-rectal biopsy
patients naif of hormonal treatment
Experimental group
Treatment:
Biological: intra-prostatic concentration of sexual steroids
Procedure: Trans-rectal biopsy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems